K-pop

NCT 127 Sells Out All Seats for Seoul Concert… A 'Green Light' for Their 5th Tour

All Three Casefordom Concerts Sold Out Set to Make a Comeback with Their 7th Studio Album in August and Embark on an Asian Tour

YUN GI BACK
2026-07-25 10:46:18
[Edaily Starin YUN GI BACK Reporter] The group NCT 127 has proven its unwavering ticket-selling power by selling out their Seoul concert, the starting point of their fifth world tour. With the release of their seventh full-length album approaching, fans’ anticipation for the new tour is also heating up.
(Photo courtesy of SM Entertainment)

According to their agency, SM Entertainment, NCT 127 will hold the Seoul leg of their fifth tour, “NEO CITY - THE REDLINE,” at the K-SPO Dome in Seoul Olympic Park from September 18 to 20. This marks their first solo concert in Korea in approximately one year and eight months.
Pre-sales for fan club members took place on the 21st and 23rd, followed by general ticket sales on the 24th, and all three shows sold out. This has been seen as further proof of the high level of interest in their first domestic concert in a long time and a reaffirmation of NCT 127’s strong fanbase.
“The Redline” is a concept symbolizing the moment of transcending limits, and the group plans to present a show that blends NCT 127’s signature intense music and performances with large-scale stage production. Expectations are high that the upgraded stage design will maximize the group’s explosive energy.
Starting with the Seoul concert, the tour will continue to major Asian cities including Jakarta, Hong Kong, Singapore, Bangkok, and Taipei. Additional dates will be announced later via official social media channels.
NCT 127 will release their seventh full-length album on the 24th of next month and kick off their full-scale comeback activities.

Economy

Corporation

IT·Science

Economy

[VC's Pick] LegalTech Firm 'Legora' Expands into Korea, Secures Series E Funding

This week (October 19–23), startups in various sectors—including accommodation solutions, AI video production, and digital healthcare—secured investments from venture capital (VC) firms and accelerato…
2026-10-24 13:07:04

Corporation

“Do I Really Need a Styler?”… I Tried This One in the 20,000-won Range [Product Review]

We’re in an era of recession-driven consumption, where we want a lot but our wallets are light. Our reporter personally tests and evaluates “value-for-money alternatives” that let you keep up with tre…
2026-10-24 10:00:03

IT·Science

Baeksite’s ‘31A’ Phase 3 Success… Competition Heats Up Ahead of SK Basa’s ‘21A’ Launch

With Baeksite successfully completing Phase 3 clinical trials for its pneumococcal vaccine “VAX-31” in adults, competition in the pneumococcal vaccine market appears to be intensifying. The vaccine fo…
2026-10-25 06:41:02